{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T20:53:32Z","timestamp":1785790412780,"version":"3.56.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2021,7,25]],"date-time":"2021-07-25T00:00:00Z","timestamp":1627171200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,7,25]],"date-time":"2021-07-25T00:00:00Z","timestamp":1627171200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Johann Wolfgang Goethe-Universit\u00e4t, Frankfurt am Main"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2021,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Treatment\u2010related complications contribute substantially to morbidity and mortality in acute myeloid leukemia (AML) patients undergoing induction chemotherapy. Although AML patients are susceptible to fluid overload (FO) (e.g., in the context of chemotherapy protocols, during sepsis treatment or to prevent tumor lysis syndrome), little attention has been paid to its role in AML patients undergoing induction chemotherapy. AML patients receiving induction chemotherapy between 2014 and 2019 were included in this study. FO was defined as \u22655% weight gain on day 7 of induction chemotherapy compared to baseline weight determined on the day of admission. We found FO in 23 (12%) of 187 AML patients undergoing induction chemotherapy. Application of &gt;100 ml crystalloid fluids\/kg body weight until day 7 of induction chemotherapy was identified as an independent risk factor for FO. AML patients with FO suffered from a significantly increased 90-day mortality rate and FO was demonstrated as an independent risk factor for 90-day mortality. Our data suggests an individualized, weight-adjusted calculation of crystalloid fluids in order to prevent FO-related morbidity and mortality in AML patients during induction chemotherapy. Prospective trials are required to determine the adequate fluid management in this patient population.<\/jats:p>","DOI":"10.1007\/s00277-021-04593-x","type":"journal-article","created":{"date-parts":[[2021,7,25]],"date-time":"2021-07-25T03:23:26Z","timestamp":1627183406000},"page":"2603-2611","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Fluid overload is associated with increased 90-day mortality in AML patients undergoing induction chemotherapy"],"prefix":"10.1007","volume":"100","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1634-1988","authenticated-orcid":false,"given":"Olivier","family":"Ballo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fagr","family":"Eladly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Koschade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"B\u00fcttner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan Alexander","family":"Stratmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uta","family":"Brunnberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva-Maria","family":"Kreisel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franziska","family":"Frank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bj\u00f6rn","family":"Steffen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hubert","family":"Serve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabian","family":"Finkelmeier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian H.","family":"Brandts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,7,25]]},"reference":[{"issue":"2","key":"4593_CR1","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1111\/bjh.13944","volume":"173","author":"R Abrah\u00e3o","year":"2016","unstructured":"Abrah\u00e3o R, Keogh RH, Lichtensztajn DY, Marcos-Gragera R, Medeiros BC, Coleman MP et al (2016) Predictors of early death and survival among children, adolescents and young adults with acute myeloid leukaemia in California, 1988\u20132011: a population-based study. Br J Haematol. 173(2):292\u2013302","journal-title":"Br J Haematol."},{"issue":"2","key":"4593_CR2","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1182\/blood-2004-01-0326","volume":"105","author":"KF Bradstock","year":"2005","unstructured":"Bradstock KF, Matthews JP, Lowenthal RM, Baxter H, Catalano J, Brighton T et al (2005) A randomized trial of high-versus conventional-dose cytarabine in consolidation chemotherapy for adult de novo acute myeloid leukemia in first remission after induction therapy containing high-dose cytarabine. Blood. 105(2):481\u20138","journal-title":"Blood."},{"issue":"1","key":"4593_CR3","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1002\/ajh.23858","volume":"90","author":"N Pemmaraju","year":"2015","unstructured":"Pemmaraju N, Kantarjian H, Garcia-Manero G, Pierce S, Cardenas-Turanzas M, Cortes J et al (2015) Improving outcomes for patients with acute myeloid leukemia in first relapse: a single center experience. Am J Hematol. 90(1):27\u201330","journal-title":"Am J Hematol."},{"issue":"2","key":"4593_CR4","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1200\/JCO.2013.52.2219","volume":"32","author":"S Sivendran","year":"2014","unstructured":"Sivendran S, Latif A, McBride RB, Stensland KD, Wisnivesky J, Haines L et al (2014) Adverse event reporting in cancer clinical trial publications. J Clin Oncol. 32(2):83\u20139","journal-title":"J Clin Oncol."},{"issue":"1","key":"4593_CR5","doi-asserted-by":"publisher","first-page":"e276","DOI":"10.1038\/bcj.2014.97","volume":"5","author":"SA Buckley","year":"2015","unstructured":"Buckley SA, Othus M, Estey EH, Walter RB (2015) The treatment-related mortality score is associated with non-fatal adverse events following intensive AML induction chemotherapy. Blood Cancer J 5(1):e276","journal-title":"Blood Cancer J"},{"issue":"2","key":"4593_CR6","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/leu.2013.176","volume":"28","author":"M Othus","year":"2014","unstructured":"Othus M, Kantarjian H, Petersdorf S, Ravandi F, Godwin J, Cortes J et al (2014) Declining rates of treatment-related mortality in patients with newly diagnosed AML given \u2018intense\u2019 induction regimens: a report from SWOG and MD Anderson. Leukemia. 28(2):289\u201392","journal-title":"Leukemia."},{"issue":"2","key":"4593_CR7","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1097\/CCM.0b013e3181feeb15","volume":"39","author":"JH Boyd","year":"2011","unstructured":"Boyd JH, Forbes J, Nakada TA, Walley KR, Russell JA (2011) Fluid resuscitation in septic shock: a positive fluid balance and elevated central venous pressure are associated with increased mortality. Crit Care Med. 39(2):259\u201365","journal-title":"Crit Care Med."},{"issue":"Suppl 1 Diagnos","key":"4593_CR8","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1186\/2110-5820-2-S1-S1","volume":"2","author":"C Cordemans","year":"2012","unstructured":"Cordemans C, De Laet I, Van Regenmortel N, Schoonheydt K, Dits H, Huber W et al (2012) Fluid management in critically ill patients: the role of extravascular lung water, abdominal hypertension, capillary leak, and fluid balance. Ann Intensive Care. 2(Suppl 1 Diagnosis and management of intra-abdominal hyperten):S1","journal-title":"Ann Intensive Care."},{"issue":"1","key":"4593_CR9","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1186\/s12887-018-1188-6","volume":"18","author":"F D\u00edaz","year":"2018","unstructured":"D\u00edaz F, Nu\u00f1ez MJ, Pino P, Erranz B, Cruces P (2018) Implementation of preemptive fluid strategy as a bundle to prevent fluid overload in children with acute respiratory distress syndrome and sepsis. BMC Pediatr. 18(1):207","journal-title":"BMC Pediatr."},{"issue":"3","key":"4593_CR10","doi-asserted-by":"publisher","first-page":"379","DOI":"10.5935\/0101-2800.20140054","volume":"36","author":"MO \u00c1vila","year":"2014","unstructured":"\u00c1vila MO, Rocha PN, Zanetta DM, Yu L, Burdmann Ede A (2014) Water balance, acute kidney injury and mortality of intensive care unit patients. J Bras Nefrol. 36(3):379\u201388","journal-title":"J Bras Nefrol."},{"issue":"7","key":"4593_CR11","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1182\/blood.V97.7.2121","volume":"97","author":"A Stucki","year":"2001","unstructured":"Stucki A, Rivier AS, Gikic M, Monai N, Schapira M, Spertini O (2001) Endothelial cell activation by myeloblasts: molecular mechanisms of leukostasis and leukemic cell dissemination. Blood. 97(7):2121\u20139","journal-title":"Blood."},{"issue":"18","key":"4593_CR12","doi-asserted-by":"publisher","first-page":"3219","DOI":"10.1002\/cncr.32196","volume":"125","author":"K Chamoun","year":"2019","unstructured":"Chamoun K, Kantarjian HM, Wang X, Naqvi K, Aung F, Garcia-Manero G et al (2019) Unrecognized fluid overload during induction therapy increases morbidity in patients with acute promyelocytic leukemia. Cancer. 125(18):3219\u201324","journal-title":"Cancer."},{"issue":"12","key":"4593_CR13","doi-asserted-by":"crossref","first-page":"e27975","DOI":"10.1002\/pbc.27975","volume":"66","author":"LH Miller","year":"2019","unstructured":"Miller LH, Keller F, Mertens A, Klein M, Allen K, Castellino S et al (2019) Impact of fluid overload and infection on respiratory adverse event development during induction therapy for childhood acute myeloid leukemia. Pediatr Blood Cancer 66(12):e27975","journal-title":"Pediatr Blood Cancer"},{"issue":"12","key":"4593_CR14","doi-asserted-by":"publisher","first-page":"2166","DOI":"10.1016\/j.bbmt.2017.08.021","volume":"23","author":"G Rondon","year":"2017","unstructured":"Rondon G, Saliba RM, Chen J, Ledesma C, Alousi AM, Oran B et al (2017) Impact of fluid overload as new toxicity category on hematopoietic stem cell transplantation outcomes. Biol Blood Marrow Transplant. 23(12):2166\u201371","journal-title":"Biol Blood Marrow Transplant."},{"issue":"12","key":"4593_CR15","doi-asserted-by":"publisher","first-page":"2517","DOI":"10.1016\/j.bbmt.2018.07.031","volume":"24","author":"C Rondon-Clavo","year":"2018","unstructured":"Rondon-Clavo C, Scordo M, Hilden P, Shah GL, Cho C, Maloy MA et al (2018) Early fluid overload is associated with an increased risk of nonrelapse mortality after ex vivo CD34-selected allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant. 24(12):2517\u201322","journal-title":"Biol Blood Marrow Transplant."},{"issue":"1 Suppl 2","key":"4593_CR16","first-page":"25","volume":"16","author":"PH Wiernik","year":"1989","unstructured":"Wiernik PH, Case DC Jr, Periman PO, Arlin ZA, Weitberg AB, Ritch PS et al (1989) A multicenter trial of cytarabine plus idarubicin or daunorubicin as induction therapy for adult nonlymphocytic leukemia. Semin Oncol. 16(1 Suppl 2):25\u20139","journal-title":"Semin Oncol."},{"key":"4593_CR17","doi-asserted-by":"publisher","unstructured":"Engelhardt M, Berger DP, Mertelsmann R, Duyster\u00a0J (eds) Das Blaue Buch, edn 6. Springer, Berlin, Heidelberg. https:\/\/doi.org\/10.1007\/978-3-662-51420-7","DOI":"10.1007\/978-3-662-51420-7"},{"issue":"3","key":"4593_CR18","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1182\/blood.V69.3.744.744","volume":"69","author":"W Hiddemann","year":"1987","unstructured":"Hiddemann W, Kreutzmann H, Straif K, Ludwig WD, Mertelsmann R, Donhuijsen-Ant R et al (1987) High-dose cytosine arabinoside and mitoxantrone: a highly effective regimen in refractory acute myeloid leukemia. Blood. 69(3):744\u20139","journal-title":"Blood."},{"issue":"51\u201352","key":"4593_CR19","first-page":"863","volume":"108","author":"U Krug","year":"2011","unstructured":"Krug U, Buchner T, Berdel WE, Muller-Tidow C (2011) The treatment of elderly patients with acute myeloid leukemia. Dtsch Arztebl Int. 108(51\u201352):863\u201370","journal-title":"Dtsch Arztebl Int."},{"issue":"3","key":"4593_CR20","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1182\/blood-2009-07-235358","volume":"115","author":"H Dohner","year":"2010","unstructured":"Dohner H, Estey EH, Amadori S, Appelbaum FR, Buchner T, Burnett AK et al (2010) Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet. Blood. 115(3):453\u201374","journal-title":"Blood."},{"issue":"4","key":"4593_CR21","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/s00277-013-1698-0","volume":"92","author":"S Neumann","year":"2013","unstructured":"Neumann S, Krause SW, Maschmeyer G, Schiel X, von Lilienfeld-Toal M, Infectious Diseases Working P et al (2013) Ann Hematol 92(4):433\u201342","journal-title":"Ann Hematol"},{"issue":"2","key":"4593_CR22","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s00277-017-3196-2","volume":"97","author":"SC Mellinghoff","year":"2018","unstructured":"Mellinghoff SC, Panse J, Alakel N, Behre G, Buchheidt D, Christopeit M et al (2018) Primary prophylaxis of invasive fungal infections in patients with haematological malignancies: 2017 update of the recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO). Ann Hematol. 97(2):197\u2013207","journal-title":"Ann Hematol."},{"issue":"4","key":"4593_CR23","doi-asserted-by":"publisher","first-page":"e56","DOI":"10.1093\/cid\/cir073","volume":"52","author":"AG Freifeld","year":"2011","unstructured":"Freifeld AG, Bow EJ, Sepkowitz KA, Boeckh MJ, Ito JI, Mullen CA et al (2011) Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of america. Clin Infect Dis. 52(4):e56-93","journal-title":"Clin Infect Dis."},{"issue":"7","key":"4593_CR24","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1111\/vox.12919","volume":"115","author":"O Ballo","year":"2020","unstructured":"Ballo O, Fleckenstein P, Eladly F, Kreisel EM, Stratmann J, Seifried E et al (2020) Reducing the red blood cell transfusion threshold from 8.0 g\/dl to 7.0 g\/dl in acute myeloid leukaemia patients undergoing induction chemotherapy reduces transfusion rates without adversely affecting patient outcome. Vox Sang 115(7):570\u20138","journal-title":"Vox Sang"},{"issue":"1","key":"4593_CR25","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s12882-016-0323-6","volume":"17","author":"R Claure-Del Granado","year":"2016","unstructured":"Claure-Del Granado R, Mehta RL (2016) Fluid overload in the ICU: evaluation and management. BMC Nephrol. 17(1):109","journal-title":"BMC Nephrol."},{"issue":"5","key":"4593_CR26","doi-asserted-by":"publisher","first-page":"R197","DOI":"10.1186\/cc11682","volume":"16","author":"ST Vaara","year":"2012","unstructured":"Vaara ST, Korhonen AM, Kaukonen KM, Nisula S, Inkinen O, Hoppu S et al (2012) Fluid overload is associated with an increased risk for 90-day mortality in critically ill patients with renal replacement therapy: data from the prospective FINNAKI study. Crit Care. 16(5):R197","journal-title":"Crit Care."},{"key":"4593_CR27","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1186\/s13054-015-1163-7","volume":"19","author":"M Ostermann","year":"2015","unstructured":"Ostermann M, Straaten HM, Forni LG (2015) Fluid overload and acute kidney injury: cause or consequence? Crit Care. 19:443","journal-title":"Crit Care."},{"issue":"3","key":"4593_CR28","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1097\/MAJ.0000000000000268","volume":"348","author":"F Rzouq","year":"2014","unstructured":"Rzouq F, Alahdab F, Olyaee M (2014) New insight into volume overload and hepatorenal syndrome in cirrhosis, \u201cthe hepatorenal reflex hypothesis.\u201d Am J Med Sci. 348(3):244\u20138","journal-title":"Am J Med Sci."},{"issue":"2","key":"4593_CR29","doi-asserted-by":"publisher","first-page":"90","DOI":"10.15420\/cfr.2015.1.2.90","volume":"1","author":"P Pellicori","year":"2015","unstructured":"Pellicori P, Kaur K, Clark AL (2015) Fluid management in patients with chronic heart failure. Card Fail Rev. 1(2):90\u20135","journal-title":"Card Fail Rev."},{"issue":"5","key":"4593_CR30","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1007\/s11739-019-02113-4","volume":"14","author":"MA Wu","year":"2019","unstructured":"Wu MA, Colombo R, Podda GM, Cicardi M (2019) Handling shock in idiopathic systemic capillary leak syndrome (Clarkson\u2019s disease): less is more. Intern Emerg Med. 14(5):723\u201330","journal-title":"Intern Emerg Med."},{"issue":"1","key":"4593_CR31","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1186\/s13054-017-1872-1","volume":"21","author":"A Perel","year":"2017","unstructured":"Perel A (2017) Iatrogenic hemodilution: a possible cause for avoidable blood transfusions? Crit Care. 21(1):291","journal-title":"Crit Care."},{"issue":"1\u20133","key":"4593_CR32","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1159\/000485153","volume":"45","author":"MJE Dekker","year":"2018","unstructured":"Dekker MJE, van der Sande FM, van den Berghe F, Leunissen KML, Kooman JP (2018) Fluid overload and inflammation axis. Blood Purif. 45(1\u20133):159\u201365","journal-title":"Blood Purif."},{"issue":"5","key":"4593_CR33","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1093\/ndt\/gfq588","volume":"26","author":"MS Demirci","year":"2011","unstructured":"Demirci MS, Demirci C, Ozdogan O, Kircelli F, Akcicek F, Basci A et al (2011) Relations between malnutrition-inflammation-atherosclerosis and volume status. The usefulness of bioimpedance analysis in peritoneal dialysis patients. Nephrol Dial Transplant 26(5):1708\u201316","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"4593_CR34","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1111\/j.1523-1755.2005.67121.x","volume":"67","author":"SL Goldstein","year":"2005","unstructured":"Goldstein SL, Somers MJ, Baum MA, Symons JM, Brophy PD, Blowey D et al (2005) Pediatric patients with multi-organ dysfunction syndrome receiving continuous renal replacement therapy. Kidney Int. 67(2):653\u20138","journal-title":"Kidney Int."},{"issue":"6","key":"4593_CR35","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1097\/DCC.0000000000000383","volume":"38","author":"J Gomes","year":"2019","unstructured":"Gomes J, Pesavento ML, de Freitas FFM, de Andrade Coelho FU (2019) Fluid overload and risk of mortality in critically ill patients. Dimens Crit Care Nurs 38(6):293\u20139","journal-title":"Dimens Crit Care Nurs"},{"issue":"12","key":"4593_CR36","doi-asserted-by":"publisher","first-page":"1862","DOI":"10.1097\/CCM.0000000000004617","volume":"48","author":"AS Messmer","year":"2020","unstructured":"Messmer AS, Zingg C, M\u00fcller M, Gerber JL, Schefold JC, Pfortmueller CA (2020) Fluid overload and mortality in adult critical care patients-a systematic review and meta-analysis of observational studies. Crit Care Med. 48(12):1862\u201370","journal-title":"Crit Care Med."},{"issue":"2","key":"4593_CR37","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/nrneph.2009.213","volume":"6","author":"JR Prowle","year":"2010","unstructured":"Prowle JR, Echeverri JE, Ligabo EV, Ronco C, Bellomo R (2010) Fluid balance and acute kidney injury. Nat Rev Nephrol. 6(2):107\u201315","journal-title":"Nat Rev Nephrol."},{"issue":"3","key":"4593_CR38","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1053\/snep.2001.21652","volume":"21","author":"M Andreucci","year":"2001","unstructured":"Andreucci M, Federico S, Andreucci VE (2001) Edema and acute renal failure. Semin Nephrol. 21(3):251\u20136","journal-title":"Semin Nephrol."},{"issue":"2","key":"4593_CR39","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.cardfail.2006.10.015","volume":"13","author":"A Boyle","year":"2007","unstructured":"Boyle A, Maurer MS, Sobotka PA (2007) Myocellular and interstitial edema and circulating volume expansion as a cause of morbidity and mortality in heart failure. J Card Fail. 13(2):133\u20136","journal-title":"J Card Fail."},{"issue":"1","key":"4593_CR40","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s00467-003-1313-z","volume":"19","author":"M Michael","year":"2004","unstructured":"Michael M, Kuehnle I, Goldstein SL (2004) Fluid overload and acute renal failure in pediatric stem cell transplant patients. Pediatr Nephrol. 19(1):91\u20135","journal-title":"Pediatr Nephrol."},{"issue":"1","key":"4593_CR41","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1378\/chest.08-2706","volume":"136","author":"CV Murphy","year":"2009","unstructured":"Murphy CV, Schramm GE, Doherty JA, Reichley RM, Gajic O, Afessa B et al (2009) The importance of fluid management in acute lung injury secondary to septic shock. Chest. 136(1):102\u20139","journal-title":"Chest."},{"issue":"2","key":"4593_CR42","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s00134-016-4573-3","volume":"43","author":"JA Silversides","year":"2017","unstructured":"Silversides JA, Major E, Ferguson AJ, Mann EE, McAuley DF, Marshall JC et al (2017) Conservative fluid management or deresuscitation for patients with sepsis or acute respiratory distress syndrome following the resuscitation phase of critical illness: a systematic review and meta-analysis. Intensive Care Med. 43(2):155\u201370","journal-title":"Intensive Care Med."}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-021-04593-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-021-04593-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-021-04593-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,6]],"date-time":"2023-11-06T12:36:59Z","timestamp":1699274219000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-021-04593-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,25]]},"references-count":42,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["4593"],"URL":"https:\/\/doi.org\/10.1007\/s00277-021-04593-x","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,25]]},"assertion":[{"value":"19 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}